Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 15130

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : September | Volume : 17 | Issue : 9 | Page : LC06 - LC10 Full Version

Perceived Stigma among Injecting Drug Users: New Evidence from an Observational Study in an Opioid Substitution Therapy Centre of Kolkata, India


Published: September 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/66301.18435
Manika Pal, Madhumita Dobe, Dipendra Narayan Goswami

1. Assistant Professor, Department of Community Medicine, ESI-PGIMSR and ESIC Medical College, Joka, Kolkata, West Bengal, India. 2. Formerly Director Professor, Department of Health Promotion and Education, All India Institute of Hygiene and Public Health, Kolkata, West Bengal, India. 3. Formerly Professor, Department of Community Medicine, IPGMER, Kolkata, West Bengal, India.

Correspondence Address :
Dr. Manika Pal,
Flat 2B, Surya Tower, 31, CC Ghosh Road, Kolkata-700008, West Bengal, India.
E-mail: drmanikapal@gmail.com

Abstract

Introduction: Injecting Drug Users (IDUs) are one of the high-risk groups for Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). Opioid Substitution Therapy (OST) is a targeted intervention for IDUs. Substance abuse, coupled with the risk of contracting HIV, makes them feel stigmatised. There can be little doubt that IDUs face discrimination and stigma in various forms, which could be a potential barrier for them to seek professional help.

Aim: To estimate the magnitude of stigma perceived by IDUs and to identify the associated factors.

Materials and Methods: An observational, cross-sectional study was conducted on IDUs attending the OST centre of Calcutta National Medical College, Kolkata, West Bengal, India from April 2016 to March 2018. A total of 168 IDUs were recruited using the census method. The Perceived Stigma of Substance Abuse Scale (PSAS) was used to determine the perceived stigma faced by the study subjects. Factors such as living arrangements, finances for addiction, level of education, emotional attachment, and religiosity were chosen as the predictor variables. Statistical Package for the Social Sciences (SPSS) version 16.0 was used for data analysis. Descriptive statistics were used to summarise the data. Logistic regression was employed to examine the associated factors with perceived stigma. The Odds Ratio (OR) with a 95% Confidence Interval (CI) was computed, and a p-value <0.05 was considered significant.

Results: Out of 168, 107 (64%) IDUs reported perceived stigma above the mean value of PSAS. A significant association between perceived stigma and immoral means of finance for addiction (AOR [CI] 4.056 [1.617-10.174]), presence of emotional attachment with any of the family members (AOR [CI] 5.652 [2.588-11.9]), and lack of religiosity (AOR [CI] 5.685 [2.588-12.489]) was observed.

Conclusion: There was an alarmingly high proportion of IDUs with perceived stigma. Immoral means of finance for addiction, lack of religiosity, and emotional attachment to family were associated with higher perceived stigma. Hence, appropriate emphasis should be given to information, education, and communication activities to address perceived stigma among IDUs in order to improve treatment adherence to OST among them. Moreover, there is a need for stigma reduction interventions in the larger community. Further research should explore the dynamics between perceived stigma and other predictor variables.

Keywords

Acquired immunodeficiency syndrome, Human immunodeficiency virus, Opioid related disorders, Substance-related disorders

Perceived stigma is the fear of discrimination that results from society’s belief (1). Among individuals with substance abuse, it creates an impact on social isolation, marginalisation, and subsequent relapse of addiction. This potentiates stigma against substance abuse in the community and hinders the control of substance-related medical and mental disorders (1),(2). IDUs have emerged as an important high-risk group for acquiring the HIV epidemic globally (3),(4),(5). OST is an HIV prevention intervention for opioid-dependent IDUs (4),(5),(6). IDUs face stigma and discrimination for substance abuse as well as the risk of contracting HIV/AIDS, which adversely affects their treatment-seeking behaviour (2). Seropositive IDU males in New York City with sex-related risky behaviour have been found to face perceived stigma within the community, manifested through separation and discrimination (2). Substance abusers face stigma in various forms, such as enacted stigma, perceived stigma, and self-stigma. Perceived stigma refers to the belief of the members of a stigmatised group about the stigmatising attitudes and actions towards them in society and the community (2). In formal health facilities in the US, IDUs face stigmatising experiences that unfavourably affect their treatment-seeking behaviour (7). The prevalence of substance abuse disorders, including injecting drug use, is on the rise; yet these disorders remain largely under treated (8). Stigma can reduce the willingness of policymakers to allocate resources. It tends to lower the motivation of healthcare workers in non specialty settings to address substance abuse problems, which may limit the eagerness of IDUs to seek treatment (8). Although most of the negative mental health outcomes could be prevented, stigma and discrimination continue to be critical challenges in mental health systems (9).

Stigma and discrimination among IDUs have been extensively studied in developed countries (8). However, relatively few studies are available in developing or less-resourced countries (10). Hence, the present study aimed to explore the stigma perceived by IDUs attending an OST centre and to determine the factors associated with stigma perceived by the study participants.

Material and Methods

An observational, cross-sectional study was conducted among IDUs attending an OST centre in the Psychiatry Campus of Calcutta National Medical College, Kolkata, West Bengal, India from April 2016 to March 2018. Ethical approval was obtained from the Ethics Committee (CNMC/8 dated 11.05.16) of the Calcutta National Medical College and Hospital, Kolkata, West Bengal, India.

Inclusion criteria: IDUs attending the centre with a clear mental state at the time of the interview, aged more than 18 years, and agreed to give informed written consent were included in the study.

Exclusion criteria: IDUs in the induction phase of OST and IDUs with severe cognitive deficits were excluded from the study.

Sample size: According to available records, 198 IDUs attended the facility daily, as OST involves directly observed therapy. The census method was followed, and the study comprised a total of 167 participants based on inclusion criteria.

Procedure

The questionnaire for the study was interviewer-administered. The purpose of the study was explained to the participants, and informed consent was obtained. Face-to-face interviews were conducted by the Principal Investigator at the OST centre, ensuring confidentiality. Each interview typically lasted for 50 minutes to one hour for each IDU. Data collection was undertaken for a period of 14 months.

The first section of the questionnaire comprised socio-demographic characteristics, including age, gender, level of education, marital status, socio-economic status (Modified BG Prasad Scale, 2016 (11). The second section contained a predesigned scale on the PSAS (12), which was used to determine the perceived stigma faced by the participants. This scale was translated into the Bengali language. Certain items required culturally relevant modifications. The translation of the scale into Bengali required three iterations of forward and back translations until the final scale was reached. The translated scale was pretested on a sample of 30 Bengali-speaking IDUs, who were asked about any word or expression that they found incomprehensible, offensive, or unacceptable. One of the items, “most people would be willing to date someone who has been treated for substance use,” required modification with respect to cultural nuances. A Cronbach’s alpha of 0.6 or more was considered satisfactory for internal consistency. The Cronbach’s alpha of the PSAS (Bengali version) was 0.675.

The scoring of PSAS was done using an 8-item four-point Likert scale. Items were numbered 1-4, with 1=strongly disagree, 2=disagree, 3=agree, and 4=strongly agree. The higher the score, the more was perceived stigma (12),(13).

The predictor variables were selected after reviewing the literature (14),(15),(16),(17).

1. Outcome variable: Higher perceived stigma- The outcome variable (perceived stigma score) was dichotomised considering the mean of the attainable perceived stigma score, i.e., 20.

2. Predictor variables:

a. Living arrangement: a) Home (Own home, rented house); b) Unstable housing (Workplace, pavement, abandoned building, jail, church, etc.)
b. Finance for addiction: a) Own legal earning or other non criminal sources; b) Immoral means.
c. Level of education: a) Level of education of middle standard and above; b) Level of education below middle standard.
d. Emotional attachment: Presence of a significant person at home- Presence of a daughter, mother, wife, or anyone whom the client is emotionally attached to- Yes/No.
e. Religiosity: Do you have faith in God? Are you strongly committed to Almighty/higher power? Yes/No.

Statistical Analysis

The SPSS version 16.0 was employed for data analysis. Descriptive statistics were used to summarise the data. Measures of central tendency and dispersion were used to summarise numerical data, while proportions were used to summarise categorical variables. The association between higher perceived stigma and different independent variables was examined using univariate and multivariable logistic regression. Odds Ratios (OR) with 95% Confidence Intervals (CI) were computed. Explanatory variables found to be statistically significant in univariate logistic regression were entered into multivariable logistic regression, and a p-value of <0.05 was considered statistically significant.

Results

Out of 168 IDUs who fulfilled the inclusion criteria and were approached and invited to participate, 167 agreed, giving a response rate of 99.4%.

Socio-demographic characteristics: As shown in (Table/Fig 1), the mean±SD age of study participants was 36.53±9.514 years. While 164 (98.2%) of the study subjects were male, only 3 (1.8%) out of 167 IDUs were females. A total of 112 (67%) participants had a low educational level, including illiterate, below primary, and primary taken together. The majority of the participants, 112 (67%), belonged to a lower socio-economic class. Forty-five (26.9%) out of 167 IDUs were never married, and 46 (27.6%) were separated or divorced.

Stigma and discrimination perceived by the study subjects: (Table/Fig 2) shows that on the PSAS, participants revealed a total mean item score of 23.6, which was well above the neutral/mean score (i.e., 20) on the scale. The total attained score had a mean±SD of 23.6±3.52, median 24, range 12 (17-29), IQR 21-26.

The study participants were grouped into two considering the mean of attainable total PSAS score of 20: a) Clients who had less perceived stigma (Total stigma score ≤20); b) Clients who had more perceived stigma (total stigma score >20). The independent variables for regression were: 1) Level of education; 2) Means of finance for addiction; 3) Religiosity; 4) Emotional attachment (presence of a significant someone at home); 5) Living arrangement.

The association between higher perceived stigma and different variables was examined through univariate logistic regression. (Table/Fig 3) showed that 107 (64%) out of 167 IDUs had higher perceived stigma. The study demonstrated that 47 (28.1%) out of 167 IDUs had “immoral means of finance for addiction,” and 70 (41.9%) had an “unstable living arrangement.” On the other hand, 86 out of 167 (51.5%) had a “lack of religiosity,” and 85 (50.9%) had “emotional attachment.” All four variables were significantly associated with higher perceived stigma and were therefore entered into multivariable logistic regression for adjustment (Table/Fig 4).

It was found that IDUs who had “immoral means of finance for addiction” had 4.056 (1.617-10.174) times higher odds of experiencing higher perceived stigma compared to those who had their own legal earnings or other non criminal sources of finance. IDUs who had ‘emotional attachment with any of the family members’ had 5.652 (2.588-11.9) times higher odds of experiencing higher perceived stigma compared to those who were not emotionally attached. IDUs whose ‘religiosity was absent’ were 5.685 (2.588-12.489) times more likely to have higher perceived stigma than those who had faith. Therefore, three out of four variables retained their significance even after adjustment. The value of Nagelkerke being 0.349 with a non significant Hosmer-Lemeshow test supported a good fit of the model.

Discussion

In this facility-based exploratory study, a high level of perceived stigma among IDUs was adeptly revealed. Additionally, the study scoringdiligently assessed the strength of the impact exerted by a range of socio-demographic factors on the experience of perceived stigma.

In the present study, the participants’ mean age was 36.53±9.514 years, with a significant majority (98.2%) being males. The level of education of 67% of the participants was low. As for marital status, it exhibited variation among the study participants, with almost 60% of the IDUs identified as single. More than a quarter (28.1%) of the IDUs were observed to resort to “immoral means of finance for addiction,” while 41.9% grappled with an “unstable living arrangement.” In contrast, 86 out of 167 participants (51.5%) reported a “lack of religiosity,” and nearly 51% exhibited “emotional attachment.” Although scores varied across items, this could be interpreted as the average participants believing that most people with substance abuse problems were devalued or discriminated against.

The study uncovered a significant proportion of heightened perceived stigma among IDUs. Within this context, several socio-demographic factors emerged as contributors to this phenomenon. Specifically, the study illuminated that 64% of IDUs experienced higher perceived stigma, considering the scale mean (20). Furthermore, the total scores obtained in the study exhibited a mean±SD of 23.6±3.52 and a median of 24. Considering that the identification of factors influencing perceived stigma among IDUs was a less explored area, this study undertook the task of unraveling the distinctive elements that shape this experience. Notably, the findings demonstrated that “Finance for addiction (Immoral Means),” “Lack of religiosity,” and “Emotional attachment” were significantly associated with an increased perception of stigma.

Rudolph AE et al., in their qualitative study in a province of Vietnam among 25 HIV positive heterosexual male IDUs, demonstrated that the participants faced elevated “perceived stigma” (2). Muncan B et al., in their qualitative study among 32 People Who Inject Drugs (PWID) in a city of America, revealed stigmatising experiences in formal healthcare settings (7). Although both studies were qualitative ones, the findings were consistent with the current study, which revealed higher perceived stigma experienced by the IDUs.

Belete H et al., in their study in Ethiopia, found that 63.9% of participants reported perceived stigma above the mean value of PSAS. A statistically significant association existed between perceived stigma and lower wealth, joblessness (18). It was consistent with present finding in which 64% of IDUs experienced higher perceived stigma and its association with immoral means of finance for addiction.

Luoma JB et al., carried out an investigation involving 197 patients receiving care at substance abuse treatment facilities to evaluate the influence of stigma on individuals with substance abuse issues (19). Their study brought to light a higher prevalence of “perceived stigma” among intravenous drug users in comparison to non IV users. Notably, almost 60% of the participants scored beyond the midpoint of the scale (19). This observation resonated with present study findings, as 64% scored above the midpoint of the scale.

In their research, Mattoo SK et al., investigated substance users undergoing treatment at a deaddiction centre in India. Their study revealed that individuals who were “presently employed” and had a “higher per-capita income” exhibited reduced perceived stigma towards substance users, as indicated by the PSAS (20). Notably, this finding aligned with the results of the present study.

Bozinoff N et al., conducted a study among 407 participants with opioid use disorder in an inpatient detoxification centre. The study revealed a higher level of both self-stigma and perceived stigma (21). The current study setting being an OST centre, the predictor variables for perceived stigma had to be different from those of a detoxification centre.

Zieger A et al., conducted a study among persons with mental illness in Chennai (n=166) and Kolkata (n=158). Link’s perceived devaluation-discrimination measure was used in the study (15). Regression analysis revealed that lower perceived stigma was associated with stronger religious devotion (p-value=0.049) and higher educational attainment (p-value=0.001) in both cities. Their finding was consistent with present study as lower perceived stigma was associated with intact religiosity.

Finally, it may be said that IDUs perceived an elevated risk of discrimination due to substance abuse, chances of contracting HIV, and consequent stigmatisation. The study brought out the uniqueness and complexity of the factors determining perceived stigma faced by the IDUs.

To the best of the authors’ knowledge, this was the first study to report on the IDUs attending the OST centre, Calcutta National Medical College, that showed a large proportion of IDUs faced perceived stigma. It was evident from the study that immoral means of finance for addiction, lack of religiosity, and emotional attachment were significantly associated with higher perceived stigma. These findings may be utilised in designing appropriate strategies to address stigma and discrimination among IDUs.

Limitation(s)

The study may have suffered from a lack of generalisability. The small sample size made it difficult to extrapolate the findings of the study to other IDUs, hence external validity could not be guaranteed. Although PSAS was validated by experts in the field, it was not formally scored. The information collected for this study relied largely on the participants’ self-reporting, which might have led to over-reporting about perceived stigma. Therefore, the proportion of IDUs with higher perceived stigma might be spurious and overestimated. Additionally, due to social desirability, some answers might have been biased and not accurate, particularly regarding sensitive questions.

Conclusion

This study provided valuable insights into the experiences of perceived stigma faced by IDUs within the community. The findings highlighted factors such as resorting to immoral means for financing addiction, lower religiosity, and strong emotional connections with family members that were associated with heightened levels of perceived stigma. These results recognise the urgency of addressing perceived stigma among IDUs and implementing stigma reduction interventions that encompass the broader community, aiming to curb the social isolation and discrimination faced by IDUs. As a final note, it is imperative to acknowledge the necessity for further research investigating the intricate relationship between perceived stigma and other predictive variables.

Acknowledgement

Authors would like to acknowledge Dr. A. Mukhopadhyay, Department of Psychiatry, Calcutta National Medical College, Kolkata, West Bengal, India. Authors would also acknowledge JB Luoma and colleagues for the adaptation of the PSAS.

References

1.
LeBel TP. Perceptions of and responses to stigma. Sociol Compass. 2008;2(2):409-32. Doi: 10.1111/j.1751-9020.2007.00081.x. [crossref]
2.
Rudolph AE, Davis WW, Quan VM, Ha TV, Minh NL, Gregowski A, et al. Perceptions of community- and family-level Injection Drug User (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care. 2012;24(2):239-44. Doi: 10.1080/09540121.2011.596517. [crossref][PubMed]
3.
Park K. Park’s Textbook of Preventive and Social Medicine. 26th ed. Jabalpur (IN): M/s Banarsidas Bhanot Publishers; 2021. Pp.391-94.
4.
Rao R, Agrawal A, Ambekar A. Opioid substitution therapy under National AIDS Control Programme: Clinical Practice Guidelines for treatment with Buprenorphine. Delhi (IN): Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2014.
5.
Rao R. The journey of opioid substitution therapy in India: Achievements and challenges. Indian J Psychiatry. 2017;59(1):39-45. Doi: 10.4103/psychiatry.IndianJPsychiatry_37_17. [crossref][PubMed]
6.
Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction. 2008;103(9):1484-92. Doi: 10.1111/j.1360-0443.2008.02249.x. [crossref][PubMed]
7.
Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. Doi: 10.1186/s12954-020-00399-8. [crossref][PubMed]
8.
Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: An international phenomenon. Curr Opin Psychiatry. 2017;30(5):378-88. Doi: 10.1097/YCO.0000000000000351. [crossref][PubMed]
9.
Ambekar A, Sethi H, Yadav D. OST program in Government health care settings: Treatment compliance and retention.[Internet] Technical Report 2012.[cited 2017 Sept 28]. Available from: http://www.researchgate.net/publication/279969525.
10.
Nair R, Nair S, Malhotra S, Sachdeva A. Shifting trends of HIV epidemiology among most at risk groups (MARGs) in India. Int J Med Sci Public Health. 2012;1:18-31. [crossref]
11.
Khairnar MR, Wadgave U, Shimpi PV. Updated BG Prasad socioeconomic classification for 2016. J Indian Assoc Public Health Dent. 2016;14:469-70. Doi: 10.4103/2319-5932.195832. [crossref]
12.
Luoma JB, O’Hair AK, Kohlenberg BS, Hayes SC, Fletcher L. The development and psychometric properties of a new measure of perceived stigma toward substance users. Subst Use Misuse. 2010;45(1-2):47-57. Doi: 10.3109/10826080902864712.[crossref][PubMed]
13.
Stringer K, Schumacher J, Turan J, Mugavero M, Kempf M, Baker E. The perceived stigma of substance abuse scale: Reliability and validity with substance using people living with HIV. Drug and Alcohol Dependence. 2015;156:e215. Doi:10.1016/j.drugalcdep.2015.07.579. [crossref]
14.
Havinga P, van der Velden C, de Gee A, van der Poel A. Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands. Harm Reduct J. 2014;11:6. Doi: 10.1186/1477-7517-11-6. [crossref][PubMed]
15.
Zieger A, Mungee A, Schomerus G, Ta TM, Dettling M, Angermeyer MC, et al. Perceived stigma of mental illness: A comparison between two metropolitan cities in India. Indian J Psychiatry. 2016;58(4):432-37. Doi: 10.4103/0019- 5545.196706. [crossref][PubMed]
16.
Grant Weinandy JT, Grubbs JB. Religious and spiritual beliefs and attitudes towards addiction and addiction treatment: A scoping review. Addict Behav Rep. 2021;14:100393. Doi: 10.1016/j.abrep.2021.100393. [crossref][PubMed]
17.
Muturi N, An S. HIV/AIDS stigma and religiosity among African American women. J Health Commun. 2010;15(4):388-401. Doi: 10.1080/10810731003753125. [crossref][PubMed]
18.
Belete H, Ali T, Mekonen T, Fekadu W, Belete T. Perceived stigma and associated factors among adults with problematic substance use in Northwest Ethiopia. Psychol Res Behav Manag. 2021;14:637-44. Doi: 10.2147/PRBM.S301251. [crossref][PubMed]
19.
Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, et al. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2007;32(7):1331-46. Doi: 10.1016/j.addbeh.2006.09.008. [crossref][PubMed]
20.
Mattoo SK, Sarkar S, Gupta S, Nebhinani N, Parakh P, Basu D. Stigma towards substance use: Comparing treatment seeking alcohol and opioid dependent men. Int J Ment Health Addiction. 2015;13:73-81. https://doi.org/10.1007/ s11469-014-9514-1. [crossref]
21.
Bozinoff N, Anderson BJ, Bailey GL, Stein MD. Correlates of stigma severity among persons seeking opioid detoxification. J Addict Med. 2018;12(1):19-23. Doi: 10.1097/ADM.0000000000000355.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/66301.18435

Date of Submission: Jun 29, 2023
Date of Peer Review: Jul 20, 2023
Date of Acceptance: Aug 27, 2023
Date of Publishing: Sep 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 03, 2023
• Manual Googling: Aug 21, 2023
• iThenticate Software: Aug 24, 2023 (9%)

ETYMOLOGY: Author Origin

EMENDATIONS: 7

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com